This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pak, R. W. Articles by Sawczuk, I. S. Search for Related Content PubMed PubMed Citation Articles by Pak, R. W. Articles by Sawczuk, I. S. Social Bookmarking                         What's this?

Review of Vitamin E and Selenium in the Prevention of Prostate Cancer: Implications of the Selenium and Vitamin E Chemoprevention Trial

Department of Urology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey

Vincent J. Lanteri, MD

Department of Urology and the Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey

John R. Scheuch, MD

Department of Urology and the Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey

Ihor S. Sawczuk, MD

Department of Urology and the Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, and the College of Physicians and Surgeons, Columbia University, New York City, New York, isawczuk{at}humed.com

The National Cancer Institute in cooperation with the Southwest Oncology Group has begun one of the largest prostate cancer prevention studies to date, the Selenium and Vitamin E Chemoprevention Trial (SELECT). The purpose of this article is to review the evidence and discuss the individual antioxidant compounds under study. The authors comprehensively reviewed the peer-reviewed literature on the chemoprevention of prostate cancer with emphasis on the antioxidants vitamin E and selenium. The credible leads for the primary prevention of prostate cancer using selenium and vitamin E have emerged as secondary findings from randomized controlled trials with corroborative evidence from observational and in vitro studies. Selenium and vitamin E are widely available compounds that are safe if taken in moderation, with relatively few adverse effects. The evidence in support of the antioxidants in the primary prevention of prostate cancer is promising, and the next step in definitively answering the question has been addressed by the investigators of SELECT. The SELECT study will define the role of the antioxidants selenium and vitamin E in the prevention of prostate cancer; complete data from the study will be available in 12 years.

Integrative Cancer Therapies, Vol. 1, No. 4, 338-344 (2002)
DOI: 10.1177/1534735402238186


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y. Xia, J. Xu, D. W Byrne, K. E Hill, and R. F Burk Reply to XL Wang Am. J. Clinical Nutrition, February 1, 2006; 83(2): 389 - 390. [Full Text] [PDF]